Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
terbinafine liconsa 250 milligram tablets
laboratorios liconsa, s.a. - terbinafine - tablets - 250 milligram - antifungals for systemic use - antifungals for systemic use - it is indicated in the treatment of the following skin and nail fungal infections: treatment of tinea corporis, tinea cruris and tinea pedis, when oral therapy is considered appropriate depending on the site, severity or extent of the infection and for the treatment of onychomycosis caused by dermatophytes
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
ibandronic acid liconsa 150 mg film-coated tablets
laboratorios liconsa, s.a. - ibandronic acid - film-coated tablet - 150 milligram(s) - bisphosphonates; ibandronic acid
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
tapentadol liconsa 100 mg prolonged-release tablets
laboratorios liconsa, s.a. - tapentadol tartrate - prolonged-release tablet - tapentadol
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
tapentadol liconsa 150 mg prolonged-release tablets
laboratorios liconsa, s.a. - tapentadol tartrate - prolonged-release tablet - tapentadol
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
tapentadol liconsa 200 mg prolonged-release tablets
laboratorios liconsa, s.a. - tapentadol tartrate - prolonged-release tablet - tapentadol
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
tapentadol liconsa 25 mg prolonged-release tablets
laboratorios liconsa, s.a. - tapentadol tartrate - prolonged-release tablet - tapentadol
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
tapentadol liconsa 250 mg prolonged-release tablets
laboratorios liconsa, s.a. - tapentadol tartrate - prolonged-release tablet - tapentadol
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
tapentadol liconsa 50 mg prolonged-release tablets
laboratorios liconsa, s.a. - tapentadol tartrate - prolonged-release tablet - tapentadol
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
losartan potassium/hydrochlorothiazide liconsa 100/25 milligram film coated tablet
laboratorios liconsa, s.a. - losartan potassium hydrochlorothiazide - film coated tablet - 100/25 milligram
Irlanda -
inglese -
HPRA (Health Products Regulatory Authority)
losartan potassium/hydrochlorothiazide liconsa 50/12.5 milligram film coated tablet
laboratorios liconsa, s.a. - losartan potassium hydrochlorothiazide - film coated tablet - 50/12.5 milligram